Clinical Trials Directory

Trials / Completed

CompletedNCT03053258

Diagnostic Breath Analysis for Detection of Ventilator Acquired Pneumonia (VAP)

Pilot Study to Evaluate Diagnostic Breath Analysis for Early Detection of Ventilator Acquired Pneumonia (VAP)

Status
Completed
Phase
Study type
Observational
Enrollment
10 (actual)
Sponsor
Landon Pediatric Foundation · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Breath samples from patients with Ventilator Acquired Pneumonia (VAP) will be analyzed to identify Volatile Organic Compounds (VOC) that have been specifically associated with VAP in previous animal models. Primary outcome measures will include the assessment of the zNose Diagnostic Breath Analysis System in the early detection of VOC's associated with VAP.

Detailed description

On clinical suspicion of VAP, breath samples will be collected from the expiratory limb of the patient's ventilator tubing circuit. A sterile Tedlar collection bag will be used to connect to the sample port and collect the breath sample. The expiratory limb sample port will be utilized to ensure maintenance of the integrity of the ventilator circuitry. The breath samples will be analyzed via the ZNose breath analysis system. Immediately following collection of breath samples, bronchoalveolar lavage fluid (BALF) will be collected and subjected to bacteriology testing for confirmation of VAP-positive and VAP-negative patients.

Conditions

Interventions

TypeNameDescription
DEVICECollection of exhaled breath sampleCollect exhaled breath sample from patients with suspected VAP

Timeline

Start date
2016-10-01
Primary completion
2018-10-01
Completion
2019-02-01
First posted
2017-02-15
Last updated
2019-05-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03053258. Inclusion in this directory is not an endorsement.